Clinical trials in San Giovanni Rotondo – page 3

154 clinical trials in San Giovanni Rotondo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

San Giovanni Rotondo at a glance

154

clinical trials

Research sites1

Quick filters

154 trials in San Giovanni Rotondo

Open in trial search

Cytomegalovirus infection+1

Recruiting

Registered drugNo placebo

A Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Maribavir
Sponsor:Gruppo Italiano Per Il Trapianto Di Midollo Osseo Cellule Staminali Emopoietiche E Terapia Cellulare

Contact Research Centre

Rectal cancer

Recruiting

Registered drugNo placebo

Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

Investigational

Italy

Participants:0–17 years
Substances:Risankizumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Daratumumab
Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Contact Research Centre

Colorectal cancer

Recruiting

Registered drugNo placebo

Study comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Fondazione GONO G.I.

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Janssen - Cilag International

Contact Research Centre

Primary biliary cholangitis

Recruiting

Investigational

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Seladelpar
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study on Cetuximab and Drug Combination for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study on Regorafenib for Patients with Advanced RAS-Mutant Colorectal Cancer Using Regorafenib and Drug Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale

Contact Research Centre

Oesophageal cancer metastatic+3

Recruiting

Registered drugNo placebo

Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Gastric cancer+3

Recruiting

Registered drug

Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Shanghai Henlius Biotech Inc.

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Luspatercept
Sponsor:Associazione Qol-One

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in San Giovanni Rotondo

What the registry says about research in the country

01 Gastrointestinal Oncology

Clinical research focusing on metastatic colorectal cancer and gastroesophageal cancers, evaluating novel combination therapies and targeted treatments.

Advanced colorectal cancer treatments
HER2-positive gastric cancer therapies
Targeted molecular therapies

02 Inflammatory Bowel Disease

Studies examining innovative treatments for Crohn's Disease and Ulcerative Colitis, testing new therapeutic combinations and treatment strategies.

Novel biological therapies
Combination treatment approaches
Disease remission strategies

03 Hematologic Malignancies

Research initiatives in acute myeloid leukemia, multiple myeloma, and other blood cancers, exploring innovative therapeutic approaches.

Targeted leukemia treatments
Novel drug combinations
Immunotherapy approaches

04 Breast and Urological Cancers

Investigations into early breast cancer treatments and therapies for prostate cancer, with focus on hormone-responsive diseases.

Endocrine therapy optimization
Advanced prostate cancer treatments
Targeted therapeutic approaches

Back to Italy All countries